[lbo-talk] India's Glenmark sells pain drug rights to Eli Lilly

uvj at vsnl.com uvj at vsnl.com
Sun Nov 18 15:17:11 PST 2007


Reuters.com

UPDATE 1-India's Glenmark sells pain drug rights to Eli Lilly http://www.reuters.com/article/companyNewsAndPR/idUSBOM28287820071030?sp=true

Tue Oct 30, 2007

(Adds more details, share price)

By Bharghavi Nagaraju

MUMBAI, Oct 30 (Reuters) - India's Glenmark Pharmaceuticals Ltd (GLEN.BO: Quote, Profile, Research) has agreed to sell the marketing rights for its experimental pain treatment molecule to Eli Lilly (LLY.N: Quote, Profile, Research) for an upfront fee of $45 million, the two firms said on Tuesday. Eli Lilly will have the rights to sell the compound, GRC 6211, in North America, Europe and Japan with Glenmark retaining the marketing rights for the rest of the world. http://www.reuters.com/article/companyNewsAndPR/idUSBOM28287820071030?sp=true



More information about the lbo-talk mailing list